Company Overview of ExSAR Corporation
ExSAR Corporation, a biopharmaceutical company, identifies, develops, and commercializes small-molecule therapeutics for protein misfolding diseases. Its products include EXR-101 for the treatment of Late-Onset Tay-Sachs; and EXR-202 for the treatment of Gaucher disease. The company provides drug discovery services to pharmaceutical, biotechnology, and academic laboratories. ExSAR Corporation was founded in 1997 and is based in Monmouth Junction, New Jersey.
11 Deer Park Drive
Monmouth Junction, NJ 08852
Founded in 1997
Key Executives for ExSAR Corporation
Similar Private Companies By Industry
|4d Molecular Therapeutics LLC||United States|
|Embolx, Inc.||United States|
|NovaRx Corporation||United States|
|Applied Veterinary Systems||United States|
|HumanZyme, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact ExSAR Corporation, please visit www.exsar.com. Company data is provided by Capital IQ. Please use this form to report any data issues.